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I first became cognizant of the massive
public health problem of tobacco use in
China at a 1985 IARC conference in
Moscow organised by David Zaridze and
Richard Peto (later Sir Richard), where
Yu-Tang Gao of the Shanghai Cancer
Institute reported that “about half of the
male adults in Shanghai are smokers.”1
Smoking prevalence in the USA had
not been that high since the early
1970s; by 1985 it was 36.8% in US white
males2 and only 23.6% in more than half
a million male participants in Cancer
Prevention Study 2.3
THE LIU STUDY
In this issue of the Journal of Epidemiology
and Community Health, Liu et al4 show
that smoking prevalence in China has
remained relentlessly high, with 54% of
men current smokers and only 8.4%
ex-smokers. Although this is an improve-
ment over the prevalence of 63% in a 1996
survey, it still has ominous implications for
life expectancy, burdens on the healthcare
system, social relationships in families and
the broader economy. Given China’s place
as the world’s most populous country,
projections of new cases and deaths from
lung and other cancers number are in mil-
lions.5 6 As Paskett has dryly observed,
“The worst is yet to come”.7
WHAT IS NEW
The Liu study provides fresh data on
exposure to tobacco promotion in many
forms, including stores, print and broad-
cast media, and public transportation.
One somewhat bright spot is that about
half of the current male smokers who had
visited healthcare providers in the preced-
ing 12 months had been advised to quit
smoking. However, it is likely that many
were in such an institution because of
existing illness. Cessation is far more
effective in those who are still healthy. It
is also disturbing that most current
smokers did not express an intention to
quit, since this is widely seen as an essen-
tial early step in the complex behavioural
process leading to cessation.8 A minuscule
proportion of current male smokers
(0.9%) had tried a ‘Western’ form of ces-
sation therapy such as nicotine replace-
ment therapy.
There is, however, opportunity for cau-
tious optimism over the long term. This
survey comes more than 10 years after
China ratified the WHO Framework
Convention on Tobacco Control, which in
principle commits it as a country to a
sweeping range of policies that have dem-
onstrably contributed to the decline in
tobacco use in Western countries, such as
smoking bans and smoke-free environ-
ments, bans on advertising and sponsor-
ship, health warnings on tobacco products
and substantial increases in excise taxes.
Unmentioned in this report, however, is
the elephant in the room, namely the
Chinese government itself. The China
National Tobacco Corporation, founded
in 1982, is the largest single manufacturer
of tobacco products in the world, and cig-
arette sales are an important domestic
revenue source. Regulation in the sense
that Americans or Europeans would rec-
ognise it is the province of the State
Tobacco Monopoly Administration
which, among other things, oversees
warning labels and compliance with
advertising restrictions. This could be
considered an archetypical conflict of
interest. As one commentator noted,
“For all practical purposes, China
National and its regulator are the same
entity: They share headquarters in
Beijing and have the same organizational
structure, the same website, and even
the same chief executive.”9
WHAT IS TO BE DONE
Nevertheless, governments do respond to
pressure. Yang reports a wide range of
legislative responses in China, including
adoption of many policies that have long
been popular in Western countries such as
bans on smoking in public places.10 He
advocates the formation of a National
Tobacco Control Bureau to coordinate
these activities. Success, however, ultim-
ately depends on how inherent intrago-
vernmental conflict plays out, and that in
turn can rest on mobilisation of extrago-
vernmental stakeholders. Chinese advo-
cates might take a leaf from other
countries, especially the USA, where the
tobacco industry, though private, is firmly
entrenched with historically strong gov-
ernmental ties and support.11 However,
the USA is also home to a wide range of
governmental and non-profit organisa-
tions that for decades have provided
support, encouragement and education
for smokers at all stages of cessation deci-
sions. Countervailing pressure has long
been bottom-up from a mixture of anti-
tobacco advocacy groups, non-profit orga-
nisations such as the American Cancer
Society and American Lung Association,
working independently and in partnership
with strong government agencies such as
the Centers for Disease Control and
Prevention and State and local health
departments. These organisations are part
of an extensive anti-smoking network in
which countering the tactics of the
tobacco industry politically takes place
alongside providing cessation advice and
services for individuals. Perhaps the
newly formed non-governmental organ-
isation China Tobacco Cessation Alliance,
a nationwide clinical system that aims to
provide hitherto unpopular cessation ser-
vices, may spark such a movement.
Halting the juggernaut of tobacco-
related deaths in China cannot be accom-
plished overnight. The extent of China’s
adherence to its commitments in the
coming decades will, to a large extent,
determine the dominance of tobacco as a
cause of death and illness. Gao told the
1985 IARC conference “there is an urgent
need to adopt effective measures against
smoking in the general public.” That
warning stands today.
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